Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Abstract
Cellular senescence is a definable fate of cells within aging, diseased, and remodelling tissues. The traditional hallmark of cellular senescence is permanent cell cycle arrest but the senescent state is also accompanied by secretion of proteins that can reinforce the senescent phenotype and adversely affect the local tissue environment. Assessment for cellular markers of senescence has revealed the existence of senescent smooth muscle cells and senescent endothelial cells in vessels of patients with atherosclerosis and hypertension. This raises the possibility that cellular senescence might contribute to the initiation or progression of vascular disease. Potential disease-promoting pathways include blunted replicative reserve, reduced nitric oxide production, and increased cellular stiffness. Moreover, the secretory phenotype of senescent vascular cells might promote vascular degeneration through chronic inflammation and extracellular matrix degradation. Slowing of vascular cell aging and selective clearing of cells that have become senescent are emerging as exciting possibilities for controlling vascular disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This expression profile is indicative of an early cellular senescence phenotype.
“This profile is indicative of an early cellular senescence phenotype62–66.”
From An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging (2021) · cites this paper as [63]
The citation lists haven’t been fetched yet
References 151 · Cited by 82
- Authors
- Yin, H., & Pickering, J. G.
- Affiliations
- Robarts Research Institute (CA)
- Western University (CA)
- Corresponding author
- Pickering, J. Geoffrey
- Venue
- Canadian Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 32
- Issue
- 5
- Pages
- 612-623
- ISSN
- 0828-282X (ISSN-L)
- OpenAlex
- W2332434525
- Cited by
- 82
- References
- 151
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 11 · 2017: 9 · 2016: 4
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Canadian Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- cellular senescence, vascular disease, atherosclerosis, hypertension, senescence-associated secretory phenotype, nitric oxide, cell stiffness, chronic inflammation, extracellular matrix degradation, vascular aging, senolytics
- MeSH terms
- Aging, Animals, Diabetes Mellitus, DNA Damage, Endothelium, Vascular, Humans, Hypertension, Inflammation, Nitric Oxide, Phenotype, Vascular Diseases, Telomere, Cellular Senescence, Oxidative Stress, Evidence-Based Medicine, Myocytes, Smooth Muscle, Endothelial Cells, Epigenesis, Genetic, Atherosclerosis, Vascular Stiffness, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review